Sanjeev Yadav, Senior Scientist, CDRI, said on Wednesday, “There are a number of such chemical compounds available but finding whether
However, with this collaboration, CSIR-CDRI Lucknow will be able to do that quickly using AI technology.”
“By combining our AI capabilities with CDRI’s capacities in drug discovery, we believe that novel candidates (compounds) that are effective and safe will be identified faster and at lower cost,” said Dr Kishan Gurram, founder and managing director of Sravathi.
“CDRI has deep expertise in cancer biology and has a demonstrated track record of drug discovery and development. It is a nodal laboratory for CSIR’s pan-cancer mission program which aims to deliver drugs to treat cancers with significant unmet needs, such as triple-negative breast cancer. This collaboration will help advance the goals of the mission”, said Radha Rangarajan, Director of CSIR-CDRI.
Advertisement
“CSIR-CDRI has developed 13 drugs from bench to market and transferred more than 80 process technologies to pharmaceutical companies. The institute is an integrated center for drug discovery with end-to-end capabilities in chemistry, biology, pharmacology, pharmacokinetics, and toxicology,” she added.
Reference :
- CSIR-CDRI to use AI for cancer treatment
– (https://www.thip.media/news/csir-cdri-to-use-ai-for-cancer-treatment/53670/)
Source: IANS
For all the latest Health News Click Here
For the latest news and updates, follow us on Google News.
Denial of responsibility! NewsBit.us is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected]. The content will be deleted within 24 hours.
